SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001274644-17-000057
Filing Date
2017-06-22
Accepted
2017-06-22 16:40:46
Documents
1
Period of Report
2017-06-20

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_149816403160205.html 4  
1 FORM 4 wf-form4_149816403160205.xml 4 3573
  Complete submission text file 0001274644-17-000057.txt   5079
Mailing Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065
Business Address 555 TWIN DOLPHIN DRIVE SUITE 615 REDWOOD CITY CA 94065 6504750158
Ocera Therapeutics, Inc. (Issuer) CIK: 0001274644 (see all company filings)

IRS No.: 631192270 | State of Incorp.: CA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O INTERWEST PARTNERS 2710 SAND HILL ROAD, SUITE 200 MENLO PARK CA 94025
Business Address
Kjellson Nina S (Reporting) CIK: 0001381980 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35119 | Film No.: 17925512